Sagittarius Life Science Corp reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 145.93 million compared to TWD 128.91 million a year ago. Net loss was TWD 23.56 million compared to TWD 20.87 million a year ago. Basic loss per share from continuing operations was TWD 0.72 compared to TWD 0.64 a year ago. Diluted loss per share from continuing operations was TWD 0.72 compared to TWD 0.64 a year ago. For the nine months, sales was TWD 447.13 million compared to TWD 413.02 million a year ago. Net loss was TWD 64.03 million compared to TWD 54.77 million a year ago. Basic loss per share from continuing operations was TWD 1.97 compared to TWD 1.68 a year ago. Diluted loss per share from continuing operations was TWD 1.97 compared to TWD 1.68 a year ago.